Newtbdrugs.org

Rifafour Working Group for New TB Drugs

WEBChemical Class: Description. Rifafour is a fixed-dose combination of the following four active TB drugs: Rifampicin 150 mg. lsoniazid 75 mg. Pyrazinamide 400 mg. Ethambutol …

Actived: 3 days ago

URL: https://www.newtbdrugs.org/pipeline/compound/rifafour

News Working Group for New TB Drugs

WEBNew Tools Summit in Paris this November. The Working Group on New TB Drugs, in collaboration with the New Diagnostics Working Group, Working Group on New …

Category:  Health Go Health

Working Group for New TB Drugs

WEBAccelerating Discovery. New treatments are critical to end the TB pandemic. The Stop TB Partnership Working Group on New Drugs helps coordinate, guide, and …

Category:  Health Go Health

PAN-TB Collaboration Announces Novel TB Drug Regimens Trial

WEBThe PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and …

Category:  Health Go Health

About Working Group for New TB Drugs

WEBAbout the Working Group. One of the Stop TB Partnership's seven Working Groups, the Working Group on New Drugs (WGND) is a network of experts committed to …

Category:  Health Go Health

Working Group for New TB Drugs

WEBThe Kick TB Campaign is a unique project that uses football (soccer), the World’s most popular sport, to educate and engage young people in the effort to stop the spread of …

Category:  Health Go Health

Interview with Stewart Cole Working Group for New TB Drugs

WEBDr. Stewart Cole. Stewart Cole helped create the Global Health Institute in 2007. Located at the Ecole polytechnique fédérale de Lausanne (EPFL), will use cutting-edge techniques …

Category:  Health Go Health

Working Group for New TB Drugs

WEBThe first ever U.N. General Assembly’s high-level meeting (UNHLM) on tuberculosis took place on Wednesday, September 26 in New York City. The U.N. delegation of countries …

Category:  Health Go Health

WHO Updates Definition of XDR-TB

WEBWHO XDR TB Pre-XDR TB drug resistance TB therapy. Last week, the World Health Organization (WHO) held a consultation to discuss the definition of extensively …

Category:  Health Go Health

An Interview with Dr. Dennis Mitchison: Part Two of a Three Part …

WEBDr. Denis Mitchison in the lab. When you think of true pioneers in research and development for the treatment of infectious diseases, Dr. Dennis Mitchison is sure to …

Category:  Health Go Health

Members Working Group for New TB Drugs

WEBMembers. The WGND is composed of diverse interested stakeholders in TB drug development, including those working in TB drug R&D, regulators, public health …

Category:  Health Go Health

Medicines Development for Global Health Working Group for …

WEBMedicines Development for Global Health is a non-profit, independent biopharmaceutical company dedicated to the development and delivery of new and improved medicines for …

Category:  Medicine Go Health

New Database Tracks Health Technology Innovations

WEBThe Center for Health Market Innovations (CHMI) has compiled profiles on over 1,200 programs and counting. The database categorizes programs into the following types: …

Category:  Health Go Health

Activities of the Tuberculosis Trials Consortium (TBTC)

WEBTuberculosis Trials Consortium (TBTC) “… is a collaboration of researchers from CDC, domestic and international public health programs, academic medical centers, and

Category:  Medical Go Health

Interview with Rebecca, a DOTS Worker in NJ – Part Two

WEBThe PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates …

Category:  Health Go Health

The War on Tuberculosis – DOTS in Newark, NJ

WEBHaile Meskel emerges from his Newark, New Jersey, row house and slips into the passenger seat of a shiny, late-model sedan, where a woman waits for him, a tiny white …

Category:  Health Go Health

Meetings Working Group for New TB Drugs

WEBKeystone Conference:Tuberculosis: Translating Scientific Findings for Clinical and Public Health Impact (X7) April 15, 2018 to April 19, 2018. Whistler, British Columbia, Canada. …

Category:  Health Go Health

TB R&D Weekly Update: Podcast interview with Dr. Gyanu …

WEBSummary: Microbial geneticist Dr. Gyanu Lamichhane of the Johns Hopkins Center for Tuberculosis Research is one of 49 recipients of the New Innovator Award, which is …

Category:  Health Go Health

Spero Therapeutics Announces Collaboration with GMRI to

WEB-- Globe Newswire reported on June 20th -- Spero Therapeutics, Inc., a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and …

Category:  Health Go Health

Blantyre Health Research and Training Trust- Blantyre ACTG CRS …

WEBTiming of antiretroviral therapy for HIV-1 infection and tuberculosis. Havlir DV, Kendall MA, Ive P, Kumwenda J, Swindells S, Qasba SS, Luetkemeyer AF, Hogg E, Rooney

Category:  Health Go Health

Interview with Dr. Lee Reichman – Part Two

WEBThis is part two of our interview, which was recorded on June 9, 2010 at the Global Tuberculosis Institute in Newark, NJ. > click here to view part one.. Dr. Lee Reichman. …

Category:  Health Go Health